WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing a category

Search
Enter keywords, a title or a report id number below.
Advanced

• SELECT SITE CURRENCY

Select a currency for use throughout the site



Analgesics

Which will be the fastest growing segment within the analgesics market this year? Which company accounted for the largest share of the UK analgesics market last year? What are the key distribution channels in the United States? Which is the leading country for analgesics in emerging economies?

The answers to these – and many more – market questions can be found in the reports, books, and subscriptions listed under Research and Markets’ Analgesics category. Our publications provide expert analysis of every aspect of the painkiller industry; for instance market trends, growth sectors, leading brands (e.g. paracetamol, ibuprofen and aspirin), and forecasts.

Key players featured include GlaxoSmithKline, United Laboratories, Bayer AG, Johnson & Johnson, and more.

For publications about vitamins, minerals and supplements please visit the Vitamins category. Show Less
... more

Sort by

Sorted by Date Published
  • Analgesics in Latvia

    Euromonitor International, Apr 2013 , Pages: 24
    Improving purchasing power changed customers’ preferences for analgesics in 2012. The customers not only bought more packaging but also chose more expensive products that were considered to be less...
  • Analgesics in Lithuania

    Euromonitor International, Apr 2013 , Pages: 25
    A slight rebound of the overall consumer health industry drove the rebound of analgesics. The category is a lot more stable compared to other OTC categories, with little innovation brewing in laboratories...
  • Analgesics in Uzbekistan

    Euromonitor International, Apr 2013 , Pages: 21
    Towards the end of the review period, analgesics continued to be one of the biggest and most dynamic categories in OTC products in Uzbekistan, as the third biggest category in current value terms. Analgesics...
  • Analgesics in Algeria

    Euromonitor International, Apr 2013 , Pages: 24
    Analgesics witnessed a solid 9% value growth in 2012, resulting from stronger demand in all categories, and more particularly, paediatric analgesics. The introduction of social security card Chifa was...
  • Analgesics in Finland

    Euromonitor International, Apr 2013 , Pages: 38
    Analgesics increased by 2% in current value terms in 2012, reaching €81 million. Despite the category being mature, positive sales were achieved by the launch of new products, new formats and new sizes...
  • Analgesics in Kazakhstan

    Euromonitor International, Apr 2013 , Pages: 22
    Towards the end of review period, analgesics was driven by the stressful and hectic lifestyle of many Kazakh consumers, particularly urban citizens, which supported the increasing demand for analgesics....
  • Analgesics in Sweden

    Euromonitor International, Apr 2013 , Pages: 31
    Consumers are increasingly treating their own minor ailments and complaints instead of visiting healthcare professionals. The growing self-medication trend in Sweden benefits sales of analgesics and...
  • Analgesics in Greece

    Euromonitor International, Apr 2013 , Pages: 27
    The grim economic situation in Greece, with disposable income shrinking at unprecedented levels, did not leave the category of analgesics unaffected. Despite the self-medication trend which tends to...
  • Analgesics in Poland

    Euromonitor International, Apr 2013 , Pages: 34
    Increasingly hectic lifestyles in Poland make more consumers suffer from stress and various aches. Many people perform stressful jobs, working long hours and allowing little or no time for balanced...
  • Analgesics in Azerbaijan

    Euromonitor International, Apr 2013 , Pages: 21
    The retailers are expanding their presence in healthcare, with an increasing number of chains amongst which Zafaran Apteki is in the lead. Besides, the number of new clinics and hospitals also is increasing....
  • Analgesics in China

    Euromonitor International, Apr 2013 , Pages: 46
    Retail sales of analgesics increased by 10% to reach RMB6.2 billion in 2012. This dynamic growth came from increasing awareness of self-medication among Chinese consumers, who are visiting chemists/pharmacies...
  • Analgesics in Chile

    Euromonitor International, Apr 2013 , Pages: 33
    Analgesics current value sales recovered after declining by 8% experienced in 2010 and marginal growth in 1% in 2011 due to the incidence of influenza A (H1N1). Growth experienced after 2010 could be...
  • Analgesics in Uruguay

    Euromonitor International, Mar 2013 , Pages: 21
    Consumers’ preference for non-steroidal anti-inflammatory drugs (NSAIDs) for fast relief of pain of different aetiology, with little or no unwanted side effects has been addressed by companies for many...
  • Analgesics in Venezuela

    Euromonitor International, Mar 2013 , Pages: 33
    Selected consumer health brands – including some analgesics- have had static prices since 2003 as a result of strict price control imposed by the Venezuelan government. Since accumulated inflation reached...
  • Analgesics in Australia

    Euromonitor International, Mar 2013 , Pages: 30
    Arthritis was a key driver of sales within analgesics in 2012. A report by Access Economics found that 3.85 million Australians suffer with a form of arthritis, with the figure expected to double by...
  • Analgesics in Croatia

    Euromonitor International, Mar 2013 , Pages: 23
    Analgesics are amongst the most heavily advertised OTC products. Modern lifestyles bring additional stress and have a negative effect on health; often manifested in the form of pain. Companies are aware...
  • Analgesics in Mexico

    Euromonitor International, Feb 2013 , Pages: 44
    The analgesics category is relatively stable, with the majority of sales held by the largest and most established brands. As a result, brands seek to differentiate themselves not only through extensive...
  • Analgesics in the United Arab Emirates

    Euromonitor International, Feb 2013 , Pages: 23
    OTC analgesics continued to face strong competition from Rx alternatives in the United Arab Emirates at the end of the review period. Many chemists/pharmacies reportedly offer higher-strength Rx products...
  • Analgesics in Saudi Arabia

    Euromonitor International, Nov 2012 , Pages: 32
    While Saudi Arabia has a strong legislative framework for the classification of OTC and Rx medicines, UTC sales of Rx medicines are widely available. If a consumer requests a brand of Rx analgesics...
  • Analgesics in Egypt

    Euromonitor International, Nov 2012 , Pages: 17
    There are no OTC analgesics available in Egypt for legal sale without a prescription. All analgesics are classified as Rx medicines in the country and are thus excluded from the scope of this research. Euromonitor...
  • Analgesics in Slovenia

    Euromonitor International, Oct 2012 , Pages: 29
    The growth in 2011 was two percentage points lower than the growth in 2010. This was mainly caused by a significant decline in the growth of Bayer Aspirin and Lekadol (acetaminophen). Euromonitor International's...
  • Disease and Therapy Review: Migraine

    Timely Data Resources, Inc, Sep 2012 , Pages: 13
    The Migraine Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and...
  • Analgesics in Kenya

    Euromonitor International, Sep 2012 , Pages: 23
    The analgesics market has grown by 8% from KES6.6 billion in 2010 to KES7.1 billion in 2011. Growth is, however, expected to slow in the coming years as the weakening shilling threatens to raise fuel...
  • Analgesics in Pakistan

    Euromonitor International, Sep 2012 , Pages: 19
    The onset of dengue fever during 2011 resulted in increased demand for analgesics during 2011, as it was the most widely recommended medication for sufferers. Consumers who suffered from fever were...
  • Analgesics in Portugal

    Euromonitor International, Sep 2012 , Pages: 27
    Due to minimal product development and stagnant prices, analgesics in Portugal recorded retail value growth of 2% in 2011. This slow growth could also be attributed to the effects of the economic recession....
  • 09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Sep 2012
    This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key...
  • Analgesics in Vietnam

    Euromonitor International, Aug 2012 , Pages: 27
    In the context of review period, the global climate change negatively affected the weather in Vietnam. For example, northern parts of the country experienced hotter summers and colder winters, whilst...
  • Analgesics in South Korea

    Euromonitor International, Aug 2012 , Pages: 36
    During July 2011, many OTC products became available through grocery retail channels in South Korea for the first time. The categories which were benefited from this include digestive remedies and topical...
  • Analgesics in Iran

    Euromonitor International, Aug 2012 , Pages: 26
    Due to the widespread consumption of RX analgesics products without prescription, consumption of analgesics is estimated to be much higher than the data projected in Euromonitor database (Euromonitor...
  • Analgesics in the Netherlands

    Euromonitor International, Aug 2012 , Pages: 26
    Current value sales of analgesics were positive in 2011 but marginally lower than 2010. Analgesics sales were impacted by changes in distribution legislation introduced during the second half of 2010...
  • Analgesics in Morocco

    Euromonitor International, Jul 2012 , Pages: 36
    The number of consumers switching to products that are perceived as being safer and as having fewer side effects continued to increase within systemic analgesics during 2011. According to trade sources,...
  • Analgesics in Serbia

    Euromonitor International, Jul 2012 , Pages: 25
    In Serbia, analgesics are considered as widely accepted and very risk-free OTC products which are able to treat a wide range of mild pain and other health problems. Due to such status amongst consumers,...
  • Analgesics in Austria

    Euromonitor International, Jul 2012 , Pages: 31
    The category of analgesics was influenced by two important factors in 2011. Firstly, the strong flu season in Austria towards the end of 2010 led to increased consumption of analgesics. Within this,...
  • Analgesics in Nigeria

    Euromonitor International, Jul 2012 , Pages: 30
    Analgesics remains one of the most popular forms of OTC in Nigeria only next to cough, cold and allergy (hay fever) remedies. Analgesics are seen by most Nigerians as on the go first aid remedies and...
  • Analgesics in Germany

    Euromonitor International, Jul 2012 , Pages: 41
    As in previous years, within overall retail value sales of analgesics, a trend away from systemic towards topical was seen in Germany in 2011. There were many factors behind the overall decline in systemic...
  • Analgesics in Italy

    Euromonitor International, Jul 2012 , Pages: 43
    Sales of analgesics continued to decline in 2011. This was due to consumers switching to Rx products such as Oki, Aulin and Nimesulide. Despite warnings of the side-effects of Rx analgesics, Italians...
  • Analgesics in Hungary

    Euromonitor International, Jul 2012 , Pages: 37
    Market growth of analgesics in 2011 was significantly affected by switch decision made in September 2010. Topical analgesics with the active ingredient of ketoprofen were switched from OTC to Rx. Although...
  • Analgesics in the Philippines

    Euromonitor International, Jun 2012 , Pages: 30
    The increasing preference for more potent and faster acting analgesics continued in 2011, due to the increasing number of Filipinos living fast-paced lifestyles. Growing demand for these types of medications...
  • Analgesics in Switzerland

    Euromonitor International, Jun 2012 , Pages: 37
    Demand for analgesics in Switzerland continued to rise during 2011 as a result of busier lifestyles and rising stress levels, a situation which is leading to higher numbers of Swiss people suffering...
  • Analgesics in Norway

    Euromonitor International, Jun 2012 , Pages: 36
    The Norwegian Medicines Agency continues to liberalise retailing of OTC medicines in Norway. The list of medicines permitted to be sold in mass retail outlets expanded after liberalisation. The government...
  • Analgesics in India

    Euromonitor International, Jun 2012 , Pages: 38
    Self-medication remained on the rise in 2011. Despite being informed regarding the dangers of overuse of systemic analgesics, consumers continued to use OTC products for mild pains. Media promotions...
  • Analgesics in the United Kingdom

    Euromonitor International, Jun 2012 , Pages: 36
    Retail value sales of analgesics in the UK declined marginally in 2011, to £518 million. The overall category continues to suffer in value terms from the growth of private label. Consumers are becoming...
  • Analgesics in Ireland

    Euromonitor International, Jun 2012 , Pages: 38
    August 2010 saw the Pharmacy Society of Ireland (PSI) introduce guidelines which restricted the display and sale of codeine-based products in pharmacies in Ireland with window displays prohibited and...
  • Analgesics in Costa Rica

    Euromonitor International, Jun 2012 , Pages: 21
    Non-steroidal anti-inflammatories (NSAIDs) continue gaining popularity as analgesic options in Costa Rica. As a consequence of on-going free trade agreements, the proliferation of imported brands from...
  • Analgesics in Belgium

    Euromonitor International, Jun 2012 , Pages: 35
    Industry consensus was that the end of 2010 and 2011 were atypically dynamic in terms of innovation. Novelties were interesting, including notably Dafalgan Agrume Effervescent, smaller variants of Dafalgan....
  • Analgesics in Singapore

    Euromonitor International, Jun 2012 , Pages: 25
    Analgesics increased by 6% in 2011, reaching S$38 million. Compared with 2010, when analgesics saw 5% growth, this positive growth in 2011 was reflective of buoyant consumer demand, new product launches...
  • 06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Jun 2012 , Pages: 40
    This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012 All companies include technology, market(s), key executive,...
  • Analgesics in Georgia

    Euromonitor International, May 2012 , Pages: 24
    Two major retail pharmacy leaders of Georgia – PSP Group and Aversi-Pharma Ltd constantly expanded their networks of chemists/pharmacies over the review period. These retailers also expand their presence...
  • Analgesics in Thailand

    Euromonitor International, May 2012 , Pages: 31
    Analgesics grew relatively well in 2011 with current value growth of 7%. Catastrophic events and relevant stress were the most overwhelming factors that prompted consumers to seek relief from analgesics....
  • Analgesics in Macedonia

    Euromonitor International, May 2012 , Pages: 23
    Analgesics benefited from growing consumer confidence in self-medication towards the end of the review period. This confidence was partly due to general trends. Stronger media consumer health coverage...
Results: First - Prev - 1 - 2 - 3 - 4 - Next - Last